• Profile
Close

Postoperative development of sarcopenia is a strong predictor of a poor prognosis in patients with adenocarcinoma of the esophagogastric junction and upper gastric cancer

American Journal of Surgery Jul 19, 2018

Kudou K, et al. - In patients with adenocarcinoma of esophagogastric junction (AEG) and upper gastric cancer (UGC), researchers evaluated if postoperative development of sarcopenia could predict a poor prognosis. Findings revealed a correlation of postoperative development of sarcopenia with poor prognosis in these patients.

Methods

  • Researchers assessed postoperative development of sarcopenia 6 months after surgery in patients with AEG and UGC who were judged as non-sarcopenic before surgery.
  • Stratification of patients into the development group or non-development group was performed.
  • The groups were analyzed in terms of clinicopathological factors and prognosis.

Results

  • The development group displayed significantly poorer 5-year overall survival rates vs non-development group (68.0% vs 92.6%, P=0.0118).
  • Postoperative development of sarcopenia was noted as an independent prognostic factor for poor overall survival in multivariate analyses (P=0.0237).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay